Diplomat Specialty Pharmacy has promoted Atheer Kaddis, PharmD, to senior vice president of sales and marketing.
Diplomat Specialty Pharmacy has promoted Atheer Kaddis, PharmD, to senior vice president of sales and marketing.
Kaddis previously served as senior vice president of managed markets and clinical services.
“Atheer is a seasoned professional who has a deep understanding of specialty pharmacy,” said Gary Kadlec, president of Diplomat. “In this new position, Atheer will bring
our sales, marketing, business development, and trade relations under one authority to allow an agile and seamless response to all of the needs of Diplomat’s clients and stakeholders.”
Kaddis said, “Coordination of our strategies within core areas of our business will allow Diplomat to become an even stronger company, exceeding the expectations of our current and future customers and partners.”
Prior to his positions at Diplomat, Kaddis served as director of pharmacy services clinical for Blue Cross Blue Shield of Michigan, where his responsibilities included formulary and clinical program development, utilization management and specialty pharmacy programs, and pay-for-performance programs.
Michigan-based Diplomat, the nation’s largest privately owned specialty pharmacy, focuses on complete medication management programs for patients across the country with serious and chronic conditions, according to a release issued by the company.
Iowa Expands PBM Legislation to Address Concerns of Independent Pharmacies
May 16th 2025A new law in Iowa, if signed by the governor, will mandate 100% pass-through of rebates, increased financial transparency, and a minimal payment for pharmacies. Critics say it will be the most costly mandate in the state’s history.
Read More
Is Arkansas’ New PBM Law the Right Path Forward for Reform? No One Knows Yet
May 9th 2025It could improve access to community pharmacies and lower prices. Or it will limit access to critical drugs and impact payers’ ability to contract for a broad range of services. Industry leaders are unsure about the impact of Arkansas’ law banning PBMs from owning pharmacies.
Read More